Direct answer
What did this PTR report?
Brad Knott reported a sale involving Oramed Pharmaceuticals Inc. - Common Stock (ORMP) (source ticker ORMP) on January 10, 2025. The source reports $15,001 - $50,000.
Open official PDF page 1 ↗U.S. House PTR · North Carolina District 13
Brad Knott
Sale · Oramed Pharmaceuticals Inc. - Common Stock (ORMP)
January 10, 2025$15,001 - $50,000Document 20027846
SALE
Verified source fields
Transaction record
- Filer
- Brad Knott
- House district
- NC13
- Asset
- Oramed Pharmaceuticals Inc. - Common Stock (ORMP)
- Official asset type
- ST · Stocks (including ADRs)
- Source ticker
- ORMP
- Transaction code
- S · Sale
- Transaction date
- January 10, 2025
- Notification date
- January 10, 2025
- Reported value
- $15,001 - $50,000
- Owner field
- Filer
- Filing status
- New
- PDF location
- Page 1 · row 3
Source context
Notes printed with this row
- Subholding of
- Charles Schwab Brokerage Account 1
Interpretation boundary
A reported transaction is not a verdict.
THIS PAGE CAN SAY
The filer, asset text, codes, dates, amount label, filing status, and notes above appear in the fingerprinted official PTR at the cited page.
THIS PAGE CANNOT SAY
A disclosed transaction is not evidence of wrongdoing, material nonpublic information, intent, profit, loss, investment performance, a current holding, net worth, or a conflict of interest. Most dollar values are disclosure ranges, not exact transaction amounts. Some amended official rows contain an exact dollar value; amount_is_exact distinguishes those rows. Numeric bounds are derived only from an unambiguous source value and the original label is always retained.
Same official filing